On April 9, 2010, Bayer HealthCare has announced that it will add a new Yasmin and Yaz warning to the labels of the two birth control pills. The new warnings will contain information about the risk of blood clots faced by women who take Yaz or Yasmin.

Teva Pharmaceuticals announced in June 2010 that it has launched a generic version of Bayer’s Yaz birth control pill, which will be marketed as Gianvi. The announcement has sparked a patent infringement lawsuit from Bayer, who claims Teva is breaking an agreement between the two companies.

The manufacturer of Yaz and Yasmin has announced that it will add a new warning about the potential risk of blood clots from the birth control pills. The new Yasmin and Yaz blood clots warning comes just weeks after similar changes were made to the drugs’ labels for prescriptions sold in the European Union. The [...]

More than 50 Indiana women have filed lawsuits against the manufacturer of Yaz and Yasmin, alleging that they developed blood clots and other side effects after using the birth control pills. More than 200 Yasmin or Yaz lawsuits have been filed against Bayer Pharmaceuticals so far.

Two new studies in the British Medical Journal have found that women taking the birth control pills Yaz and Yasmin face twice the risk of blood clots as those who are prescribed another contraceptive pill. The two studies found the increased blood clot risk also extended to other birth control pills that contain the hormone [...]

The manufacturer of Yaz has begun airing a $20 million ad campaign aimed at correcting the “false and misleading” claims about the birth control pills it had made in previous advertisements. Bayer Pharmaceuticals began airing the ads two weeks ago following a crackdown by the Food and Drug Administration and the attorneys general of 27 [...]